- Job Market Politics to Keep Interest Rates Low
- AIG, Symbol of Crisis, Watches Its Stock Zoom Back
- Disney Profit, Sales Top Street Forecasts; Shares Jump
- Bill Gates Praises Apple's Jobs for 'Saving the Company'
- Cities With the Most Home Price Reductions
- Cramer: The Real Reason Stocks Fell Thursday
- Is Euphoric Market Ignoring Warning Signs?
- Video Game Sales Plunge, but Have They Hit Bottom?
- Despite Rhetoric, Obama Has Few Options to Boost Jobs
- Microsoft's Bill Gates Praises Apple's Steve Jobs For 'Saving the Company'
- Gold Is a Bad Inflation Hedge—Like Oil: Stock Picker
- Intel's Andy Bryant Offers An Explanation
- US 'Actively Working' on Weaker Dollar: Fund Manager
- Options Boil on Biotech Buyout Rumors
- Warren Buffett's $100,000 Offer and $500,000 Advice for Columbia Business School Students
- Activision Blizzard's "Modern Warfare 2" Sales Break Records
- 5-Star Manager's 5 Stocks for Changing Markets
- What's The Forecast from Retailers? Proceed With Caution
MOST SHARED
- Warren Buffett and Bill Gates Share Their 'Optimism' With Eager Columbia Business Students
- Cities With the Most Home Price Reductions
- Pharma & Social Media
- Warren Buffett's $100,000 Offer and $500,000 Advice for Columbia Business School Students
- Disney Profit, Sales Top Street Forecasts; Shares Jump
- China Fourth Quarter Growth Could Hit 10%: Official
- Despite Rhetoric, Obama Has Limited Options To Boost Jobs
- Disney CFO and Parks Chief to Swap Roles
- Housing Recovery 'Still In Uncharted Territory': HUD Secretary
Text Size 
The wall between a prestigious medical journal and a major drug company may have been shattered.
 |
Alastair Grant / AP GlaxoSmithKline headquarters in London. |
The scientific journal Nature reported today that a peer-reviewer for The New England Journal of Medicine leaked key study results on GlaxoSmithKline's diabetes drug Avandia to the company weeks before they were published.
Steven Haffner with the University of Texas Health Science Center in San Antonio faxed the study to a Glaxo [GSK
Loading...
()
] employee he had worked with on an earlier Avandia study.
Haffner told Nature, "Why I sent it is a mystery. I don't really understand it. I wasn't feeling well. It was bad judgment. I've got a considerable amount of money. I didn't do it to raise my income or anything like that."
Today, Senator Chuck Grassley, the ranking member of the Senate Finance Committee, sent this letter inquiring about the leak to Glaxo's top U.S. executive.
The study in question--an analysis of many clinical trials--showed that Avandia may increase the risk of heart attacks. UK-based Glaxo's stock plummeted when the results were released May 21.
The Food and Drug Administration put a stiff warning on Avandia's label over the findings.
A Glaxo spokesperson told Nature that the inside knowledge that the company had about the study's pending publication "added an additional sense of urgency" to swiftly get the interim results of a more favorable Glaxo-sponsored study published in NEJM.
Peer-reviewers who break confidentiality rules are typically banned from doing future reviews and writing articles or editorials.
The Glaxo employee who received the fax is the senior director of the company's Metabolism Development Center. A Glaxo spokesperson said Haffner sent the study to the employee to get his take on it, but the company told Haffner it couldn't help him.
The spokesperson says the Glaxo executive "didn't do anything wrong."
Print
Email
- Warren Buffett and Bill Gates spoke to Columbia students, and Buffett made the students a startling offer.
- They may have wrecked their companies or saved our economy. Tell us what you think.
- Big pharma embraces social media, but how much should a tightly regulated sector say on Facebook or Twitter?
- A European dating site finds lovelorn singles from one country to be consistently uglier. Which is it?
- Contributor David Pogue looks at two of the latest efforts to perfect the digital pocket camera.
- PepsiCo is ramping up its onsite health facilities for workers.
Data is a real-time snapshot *Data is delayed at least 15 minutes